%D8%B0%D8%A6%D8%A8%D8%A9_%D8%AD%D9%85%D8%A7%D9%85%D9%8A%D8%A9Lupus_erythematosus%D9%84%D9%88%D9%BE%D9%88%D8%B3_%D8%A7%D8%B1%DB%8C%D8%AA%D9%85%D8%A7%D8%AA%D9%88%D8%B3Lupus_%C3%A9ryth%C3%A9mateux%E0%A4%B0%E0%A4%95%E0%A5%8D%E0%A4%A4%E0%A4%BF%E0%A4%AE_%E0%A4%B2%E0%A5%8D%E0%A4%AF%E0%A5%82%E0%A4%AA%E0%A4%B8LupusoLupus_eritematosoLupusLupus_erythematodesTocze%C5%84_rumieniowatyL%C3%BApus_eritematosoLupus_ban_%C4%91%E1%BB%8FQ188297%E7%B4%85%E6%96%91%E6%80%A7%E7%8B%BC%E7%98%A1
about
P101
P1050
Recurrent severe aseptic meningitis after exposure to lamotrigine in a patient with systemic lupus erythematosus.Insulin Resistance and Atherosclerosis in Women With LupusEvaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus ErythematosusComparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus NephritisTNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)Auto-immunity in Lupus Patients After Influenza VaccinePrevalence and Clinical Severity of Cutaneous Lupus ErythematosusA Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus ErythematosusStudy Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)GENetic & Immunologic Abnomalies in Systemic Lupus ErythematosusDuke Lupus RegistryInteractive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus ErythematosusStudy of Epratuzumab in Systemic Lupus ErythematosusStudy of LJP 394 in Lupus Patients With History of Renal DiseaseGL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With GlucocorticoidsTrial of Belimumab in Early LupusMulticomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLEZostavax in Systemic Lupus ErythematosusBalancing Lupus Experiences With Stress StrategiesEffect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus ErythematosusGSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast AsiaSpine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on ChildrenTo Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus ErythematosusEvaluation of the Influence of Food Regimen on Oshadi D AbsorptionA Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus ErythematosusOmega-3 Replacement With Krill Oil in Disease Management of SLEFLARE Lupus Research Study Systemic Lupus ErythematosusBlood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy VolunteersPilot Trial of Mesenchymal Stem Cells for Systemic Lupus ErythematosusInternet-Based Pain Coping Skills Training for Patients With LupusImplementing the Decision-Aid for Lupus (IDEAL Strategy)
P921
Q1228801-F9F8064A-1C44-48AF-94BE-DC1DC37EBE69Q1485-F734C4BD-896D-4DD6-AB47-242BDE5FE4B8Q18553226-816D1D95-6A89-4585-8146-106E0D86AD86Q2785159-823c738b-4b0f-5205-5bd4-bf0a09cf2c2cQ5097618-a9976900-40ca-6b77-af6f-3c79b3dd3934Q6704853-85d81fc2-4fc4-6866-dc48-1cc38a0a1049Q6993491-bbfe9ee6-4d29-bfb1-5d31-82fa95d57e14Q7371885-441d0302-4d87-9b63-1c65-0a3430620234
P279
Q45243595-de0e4330-474f-07d4-c0bc-d5afa15bf933Q61865109-13217D6B-4AC9-4113-913C-2F2B9917DF14Q61915557-DDE809D6-4374-40AA-8FA1-82490E384FF4Q61921600-9B364779-3462-4B52-B630-DA5756834203Q61922177-B21786AC-5BEB-459C-AE0A-79740BD5F652Q61933146-BEA29058-1C90-445D-BF1B-ACD2AF17FB14Q61933176-3BD08E36-D4EE-48BD-B265-AEAA00E1707EQ61933752-94216115-2D33-4856-AFF2-21A38C7EFA97Q61936835-166EEC09-AEDF-4438-895E-D002BC90B9BDQ61938530-48AADEBA-593D-457F-95A4-D0ED753A24FEQ61956265-F2010373-A13B-4621-888E-212B4727178EQ61956281-5159AA12-D618-4502-97D6-226DA6715E4BQ61967656-20FFD27B-5907-4401-BBC3-E7881F75B300Q61969925-A36F4F01-29FA-453B-A2DA-2392ACCD34C5Q61979015-95894722-6B0A-4B94-84A4-2EAA165598B9Q62034440-89A4122A-7637-4FA4-943F-85B35F09575FQ62105167-157C39E9-6F11-487E-A32E-150AFFB32B14Q62109979-233C379F-958E-43B6-8C14-47707829CB4FQ62110368-EE4385E6-E0C6-4091-8D86-729CF993CD08Q62810978-FCF1FC50-9B1F-49A3-A073-116C894E94DAQ62813493-3388ECF7-A9F5-4344-97EF-164C6C6939DEQ63321192-5C158477-6071-405B-9878-014FEF424E1FQ63334449-AF444063-55BD-42D1-B9F5-EF52601800A1Q63335919-542AC02C-1666-4EDD-A4CC-0E109ED1D294Q63336423-15BCE805-A5EF-4849-AD00-92C858FA9E81Q63338006-DDA3D25D-47E4-4A9C-A84C-E4FC8504EEDEQ63338249-B04D7DAA-46AA-4B62-8101-D04D03453C83Q63338755-66A8F878-75CA-4E0B-A4DF-362D3A58E81EQ63340282-AC2872C7-A3A9-47B4-A3D0-57E7E6316730Q63393717-5636AB28-D17E-421A-AA74-C7C046099F74Q63401503-3786827D-9E4F-4B29-8763-B643A8AFDBC3Q63571828-28BA7A11-BAED-406D-B0B7-55D8F750A647Q63576155-CADF81DC-2933-4EF0-8B10-9781C6A47C40Q63576191-4241A408-D766-4AFF-8ED9-E2178EC262C7Q63596210-4F8E8868-BE46-4484-9CAC-EF654203B62E
P921
description
Autoimmuunisairaus, ks. Systeeminen lupus erythematosus
@fi
Human disease
@en
Kolagenoari eragiten dion gait ...... arne-organoei ere eragiten die
@eu
Krankheit
@de
malattia cronica di natura aut ...... si organi e tessuti del corpo.
@it
مرض يصيب الإنسان
@ar
一系列自体免疫性疾病
@zh
name
Lupus ban đỏ
@vi
Lupus erythematodes
@nl
Lupus
@id
Lupus
@jv
Lupus
@lfn
Lupuso
@io
Lúpus eritematoso
@pt
Toczeń rumieniowaty
@pl
eritema-lupus
@eu
lupus eritematoso
@es
type
label
Lupus ban đỏ
@vi
Lupus erythematodes
@nl
Lupus
@id
Lupus
@jv
Lupus
@lfn
Lupuso
@io
Lúpus eritematoso
@pt
Toczeń rumieniowaty
@pl
eritema-lupus
@eu
lupus eritematoso
@es
altLabel
Lupus Erythematosus
@en
Lupus erythematosus (disorder)
@en
Lupus erythematosus NOS (disorder)
@en
Lupus erythematosus
@nl
Punahukka
@fi
Systeeminen lupus erythematosus
@fi
lupus eritematoso
@eu
lupus
@en
英:ループス
@ja
prefLabel
Lupus ban đỏ
@vi
Lupus erythematodes
@nl
Lupus
@id
Lupus
@jv
Lupus
@lfn
Lupuso
@io
Lúpus eritematoso
@pt
Toczeń rumieniowaty
@pl
eritema-lupus
@eu
lupus eritematoso
@es
P508
P6366
P646
P1296
P1417
science/lupus-erythematosus
P1692
P1748
P1995
P2892
P31
P4746
P5270
MONDO:0004670
P6366
2775915377
P646
/m/057xmrj